LONDON SURGICAL ONCOLOGY LIMITEDActive

Company number 08418086Private limited companyIncorporated 2013

Key figures

£3,740,685+0.4%
Net assets 2024/25
+0.1%
Average annual growth 2019/20–2024/25
01 m2 m3 m4 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, LONDON SURGICAL ONCOLOGY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m6 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand2,874,0902,851,9292,914,8762,813,5793,077,709
Total assets3,706,5473,679,0483,694,1153,756,1844,019,568
Total liabilities54,10540,908102,76131,804278,883
Net assets / total equity3,652,4423,638,1403,591,3543,724,3803,740,685
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: LONDON SURGICAL ONCOLOGY LIMITED

Company

LONDON SURGICAL ONCOLOGY LIMITED is a private limited company registered with Companies House under company number 08418086. It was incorporated on 25 Feb 2013. Its status is active. The registered office is in London (SW15). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files small company accounts (filleted). Net assets were £3,740,685, up 0.4% on the previous year. Cash at bank and in hand was £3,077,709. Total assets were £4,019,568 and total liabilities £278,883. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 11 Mar 2027.